Abstract:Tigecycline and colistin are few of last-resort defenses used in anti-infection therapies against carbapenem-resistant bacterial pathogens. The successive emergence of plasmid-borne tet (X) tigecycline resistance mechanism and mobile colistin resistance ( mcr ) determinant, renders them clinically ineffective, posing a risky challenge to global public health. Here, we report that co-carriage of tet (X6) and mcr-1 gives co-resistance to both classes of antibiotics by a single plasmid in E. coli . Genomic analysis suggested that transposal transfer of mcr-1 proceeds into the plasmid pMS8345A, in which a new variant tet (X6) is neighbored with Class I integron. The structure-guided mutagenesis finely revealed the genetic determinants of Tet(X6) in the context of phenotypic tigecycline resistance. The combined evidence in vitro and in vivo demonstrated its enzymatic action of Tet(X6) in the destruction of tigecycline. The presence of Tet(X6) (and/or MCR-1) robustly prevents the accumulation of reactive oxygen species (ROS) induced by tigecycline (and/or colistin). Unlike that mcr-1 exerts fitness cost in E. coli, tet (X6) does not. In the tet (X6)-positive strain that co-harbors mcr-1 , tigecycline resistance is independently of colistin resistance caused by MCR-1-mediated lipid A remodeling, and vice versa. Co-production of Tet(X6) and MCR-1 gives no synergistic delayed growth of the recipient E. coli . Similar to that MCR-1 behaves in the infection model of G. mellonella , Tet(X6) renders the treatment of tigecycline ineffective. Therefore, co-transfer of such two AMR genes is of great concern in the context of “one health” comprising environmental/animal/human sectors, and heightened efforts are required to monitor its dissemination. Author summary We report that tet (X6), a new tigecycline resistance gene, is co-carried with the other resistance gene mcr-1 by a single plasmid. Not only have we finely mapped genetic determinants of tet (X6), but also revealed its biochemical action of tigecycline destruction. Crosstalk of Tet(X6) with MCR-1 is addressed. Tet(X6) tigecycline resistance is independently of MCR-1 colistin resistance, and vice versa. Similar to MCR-1 that renders colistin clinically ineffective, Tet(X6) leads to the failure of tigecycline treatment in the infection model of G. mellonella . This study extends mechanistic understanding mechanism and interplay of Tet(X6) and MCR-1, coproduced by a single plasmid. It also heightens the need to prevent rapid and large-scaled spread of AMR. ### Competing Interest Statement The authors have declared no competing interest.

Putative dioxygen-binding sites and recognition of tigecycline and minocycline in the tetracycline-degrading monooxygenase TetX

Structural and mechanistic basis of the high catalytic activity of monooxygenase Tet(X4) on tigecycline

Binding of Tetracyclines to Acinetobacter baumannii TetR Involves Two Arginines as Specificity Determinants

Identification of OxyE as an Ancillary Oxygenase during Tetracycline Biosynthesis

A novel inhibitor of monooxygenase reversed the activity of tetracyclines against tet(X3)/tet(X4)-positive bacteria

Crystal Structures of Multidrug Binding Protein TtgR in Complex with Antibiotics and Plant Antimicrobials

Additional File 7 of Structural and Mechanistic Basis of the High Catalytic Activity of Monooxygenase Tet(X4) on Tigecycline

Tetracenomycin X Inhibits Translation by Binding Within the Ribosomal Exit Tunnel

Sequence-structure-function characterization of the emerging tetracycline destructase family of antibiotic resistance enzymes

Transferability of Tigecycline Resistance: Characterization of the Expanding Tet(X) Family

Structural basis for differential inhibition of eukaryotic ribosomes by tigecycline

Specific binding of divalent metal ions to tetracycline and to the Tet repressor/tetracycline complex

Genome mining of the biosynthetic gene cluster of the polyene macrolide antibiotic tetramycin and characterization of a P450 monooxygenase involved in the hydroxylation of the tetramycin B polyol segment.

Tetracycline-inactivating enzymes from environmental, human commensal, and pathogenic bacteria cause broad-spectrum tetracycline resistance

Analysis of tigecycline resistance development in clinical Acinetobacter baumannii isolates through a combined genomic and transcriptomic approach

Identification of Novel Tetracycline Resistance Gene Tet(x14) and Its Co-Occurrence with Tet(x2) in a Tigecycline-Resistant and Colistin-Resistant Empedobacter Stercoris

Genetic characterization of enzymes involved in the priming steps of oxytetracycline biosynthesis in Streptomyces rimosus.

Emerging High‐Level Tigecycline Resistance: Novel Tetracycline Destructases Spread via the Mobile Tet(X)

The Tigecycline Resistance Gene Tetx Has an Expensive Fitness Cost Based on Increased Outer Membrane Permeability and Metabolic Burden in Escherichia Coli.

Resistance and Phylogeny Guided Discovery Reveals Structural Novelty of Tetracycline Antibiotics

Mechanistic Insights into Crosstalk of Tet(X) and MCR-1, Two Resistance Enzymes Co-produced by A Single Plasmid